NOVT

Novanta Inc.

Price

$145.94

return (12m)

21.43%

p/e

111.25

p/bv

4.25

DIVIDEND YIELD

0.00%

NOVT price

Novanta

If you had invested

exposure

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

Return on Investment NOVT

1 month

3 months

1 year

2 years

5 years

10 years

return

1 month

-1.58%

3 months

-5.77%

1 year

21.43%

2 years

-19.44%

5 years

-0.48%

10 years

752.95%

Asset Comparator

If you had invested

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

Fundamentals NOVT

Valuation

P/E

111.25

Sector -2.19

Industry 1.21

P/BV

4.25

Sector 2.22

Industry 2.11

P/Revenue (PSR)

6.67

Sector 2.01

Industry 0.78

EV/EBITDA

140.24

Sector -17.81

Industry -25.30

EV/EBIT

207.47

Sector -26.72

Industry -18.04

P/EBITDA

37.85

Sector 0.36

Industry 0.18

P/EBIT

57.29

Sector -3.34

Industry 1.26

P/Total Assets

3.21

Sector 1.23

Industry 0.86

P/Net Current Assets

11.44

Sector -27.35

Industry -12.37

P/Working Capital

7.83

Sector -4.54

Industry -49.48

EPS

1.51

Sector -0.87

Industry -0.55

BVPS

39.43

Sector 3.80

Industry 5.36

Efficiency

Gross Margin

44.54%

Sector 43.36%

Industry 31.53%

EBITDA Margin

17.01%

Sector -323.65%

Industry -73.39%

EBIT Margin

11.50%

Sector -194.57%

Industry -11.94%

Operating Margin

11.65%

Sector -24.37%

Industry -9.87%

Net Profit Margins

6.00%

Sector -28.88%

Industry -19.76%

Asset Turnover

0.12

Sector 0.12

Industry 0.22

Profitability

ROE

3.82%

Sector -33.82%

Industry -37.56%

ROA

2.89%

Sector -29.63%

Industry -17.56%

ROIC

7.43%

Sector -431.16%

Industry -111.59%

Dividends

Dividend yield

0.00%

Sector -

Industry -

Payout

0.00%

Sector -

Industry -

Debt

Current Ratio

4.57

Sector 1.84

Industry 1.14

Net Debt / EBITDA

-11.73

Sector -1.47

Industry -31.86

Net Debt / EBIT

-17.36

Sector -1.32

Industry 2.06

Net Debt / Equity

-0.33

Sector -0.35

Industry 0.14

Gross Debt / Equity

0.12

Sector 0.14

Industry 0.51

Equity/Assets

0.76

Sector 0.42

Industry 0.25

Liabilities/Assets

0.24

Sector 0.46

Industry 0.46

Growth

5Y Revenue CAGR

7.82%

Sector -

Industry -

5Y Earnings CAGR

4.18%

Sector -

Industry -

FAIR VALUE OF Novanta ACCORDING TO BENJAMIN GRAHAM

Graham's Fair Value

The Fair Value formula was created by Benjamin Graham to identify stocks with appreciation potential or that are being traded for less than they are worth. Graham was one of the greatest investors in history and Warren Buffett’s mentor.

Current price

$145.94

Fair Value

$36.60

Upside Return potential.

-74.92%

See Graham's ranking

Because it considers equity value in its calculation, this formula may not work well for technology companies.

This is not a buy/sell recommendation; the fair value calculation takes into account only the formula created by Benjamin Graham, published in the book The Intelligent Investor.

Fundamentals NOVT

DRAG THE FRAME TO SEE MORE DATA

Assets	Price (US$)	Return 12m	DY	P/E	P/BV	ROE	Net Profit Margins
NOVT Novanta Inc.	$145.94	21.38%	0.00%	111.25	4.25	3.82%	6.00%
ISRG Intuitive Surgical Inc.	$397.72	-17.36%	0.00%	45.09	7.73	17.15%	28.45%
ABT Abbott Laboratories	$114.43	-11.62%	2.33%	33.60	3.57	10.61%	11.65%
MDT Medtronic PLC	$94.13	4.71%	3.10%	24.50	2.35	9.59%	13.20%
BSX Boston Scientific Corp.	$52.01	-49.87%	0.00%	18.98	0.00	-%	19.57%
TMDX TransMedics Group Inc.	$93.97	-25.21%	0.00%	20.36	5.96	29.28%	22.69%
IDXX IDEXX Laboratories Inc.	$562.20	-11.86%	0.00%	38.32	27.08	70.67%	25.03%
RMD ResMed Inc.	$230.65	-18.34%	1.07%	21.40	4.95	23.13%	26.94%
COHR Coherent Inc.	$287.47	217.68%	0.00%	79.32	5.68	7.16%	11.31%
PHG Koninklijke Philips NV	$27.62	4.58%	3.70%	20.19	1.98	9.80%	6.30%
SYK Stryker Corp.	$339.98	-9.77%	1.02%	34.97	5.44	15.55%	14.43%
INMD InMode Ltd.	$15.04	5.14%	0.00%	11.54	1.42	12.32%	20.69%
DXCM DexCom Inc.	$89.88	11.21%	0.00%	34.58	13.19	38.14%	20.12%
EW Edwards Lifesciences Corp.	$92.28	17.85%	0.00%	52.70	4.94	9.37%	15.43%
BDX Becton Dickinson and Company	$187.60	-0.85%	2.30%	53.25	2.05	3.85%	4.05%
IMRA Imara Inc.	$0.00	-100.00%	92.02%	65.05	1.13	1.74%	0.00%
BDXB Becton Dickinson and Company	$0.00	-100.00%	0.00%	8.75	0.54	6.12%	8.36%
ALGN Align Technology Inc.	$163.04	13.40%	0.00%	28.99	2.83	9.77%	9.99%
ABMD Abiomed Inc.	$0.00	-	0.00%	64.27	11.14	17.32%	24.84%
IRMD iRadimed Corporation	$87.40	26.40%	1.45%	48.10	10.90	22.66%	26.71%
SNN Smith & Nephew PLC	$29.30	-16.53%	2.61%	11.16	2.43	21.74%	9.20%

Stock vs Indice Comparison Tool

If you had invested

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

NOVT Historical Dividends

current DY: 0.00%

5-year average DY: 0.00%

no dividend paid in the period.

ABOUT Novanta

Novanta Inc.

Average Investor10 user rating

4.0 (1 people)

United States

56 years

Founded: 1970

1999

Time since IPO - 27 years

1.269

Employees

Novanta Inc. (United States) is listed on the Nasdaq and has a market capitalization of $6.87 billion, with shareholders equity totaling $1.62 billion.

The company employs approximately 1.269 people and operates in the Health sector, within the Medical Supplies and Equipment industry.

Over the past 12 months, Novanta Inc. reported $1.03 billion in revenue, generating net income of $61.76 million.

Key financial metrics include a P/E ratio of 111.25, a price-to-book (P/B) ratio of 4.25, and a trailing twelve-month dividend yield of 0.00%.

The company trades under the ticker NOVT.

Market cap

$6.87 billion

Net worth

$1.62 billion

$1,616,460,000.00

Assets

$2.14 billion

$2,139,570,000.00

Total Shares Outstanding

41.00 million

41,000,000

Average Daily Trading Volume

$525.54 Thousand

$525,542.00

Sector

Health

Industry

Medical Supplies and Equipment

NOVT

NOVT revenue and profits

Financial Results NOVT

DRAG THE FRAME TO SEE MORE DATA

NOVT cash flow

DRAG THE FRAME TO SEE MORE DATA

Discover more assets

CVS - CVS Health

$93.65 36,41% (12M)

P/E

25.48

2.73%

ROE

6.12%

P/BV

1.56

CI - Cigna

$277.45 --6,37% (12M)

P/E

10.82

2.19%

ROE

16.04%

P/BV

1.74

CNC - Centene

$64.69 120,03% (12M)

P/E

-6.48

0.00%

ROE

-22.51%

P/BV

1.46

HUM - Humana

$378.02 32,24% (12M)

P/E

36.20

0.92%

ROE

6.63%

P/BV

2.40

SNY - Sanofi

$45.83 --5,73% (12M)

P/E

7.10

4.04%

ROE

18.43%

P/BV

1.31

LLY - Eli Lilly

$1,280.34 81,92% (12M)

P/E

39.62

0.54%

ROE

78.84%

P/BV

31.24

HCA - HCA Healthcare

$407.05 --0,11% (12M)

P/E

13.12

0.74%

ROE

-213.15%

P/BV

-27.97

NVS - Novartis

$160.31 28,43% (12M)

P/E

22.57

2.05%

ROE

30.41%

P/BV

6.87